Atlas Trials

Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)

Clinical trial NCT00452218 · COMPLETED

Trial details

NCT number
NCT00452218
Sponsor
University of Chicago
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pulmonary Arterial Hypertension
Start date
2007-03-01
Primary completion
2012-05-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.